UniProt ID | FCL_HUMAN | |
---|---|---|
UniProt AC | Q13630 | |
Protein Name | GDP-L-fucose synthase | |
Gene Name | TSTA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 321 | |
Subcellular Localization | ||
Protein Description | Catalyzes the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction.. | |
Protein Sequence | MGEPQGSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MGEPQGSMRILVTG -CCCCCCCEEEEEEC | 10.31 | 24719451 | |
13 | Phosphorylation | GSMRILVTGGSGLVG CCEEEEEECCCCHHH | 32.17 | 20068231 | |
16 | Phosphorylation | RILVTGGSGLVGKAI EEEEECCCCHHHHHH | 30.23 | 20860994 | |
21 | Ubiquitination | GGSGLVGKAIQKVVA CCCCHHHHHHHHHHH | 34.53 | 21906983 | |
25 | Ubiquitination | LVGKAIQKVVADGAG HHHHHHHHHHHCCCC | 32.34 | - | |
42 | Phosphorylation | GEDWVFVSSKDADLT CCCEEEEECCCCCCC | 21.87 | 28348404 | |
43 | Phosphorylation | EDWVFVSSKDADLTD CCEEEEECCCCCCCC | 29.29 | 28348404 | |
44 | Ubiquitination | DWVFVSSKDADLTDT CEEEEECCCCCCCCH | 49.80 | 21906983 | |
81 | Acetylation | GGLFRNIKYNLDFWR HHHHHHHCCCHHHHH | 31.47 | 26051181 | |
82 | Phosphorylation | GLFRNIKYNLDFWRK HHHHHHCCCHHHHHH | 19.70 | 27251275 | |
89 | Ubiquitination | YNLDFWRKNVHMNDN CCHHHHHHCCCCCCC | 54.65 | - | |
111 | Phosphorylation | VGARKVVSCLSTCIF HCHHHHHHHHHHCCC | 16.60 | 30622161 | |
114 | Phosphorylation | RKVVSCLSTCIFPDK HHHHHHHHHCCCCCC | 26.09 | 30622161 | |
115 | Phosphorylation | KVVSCLSTCIFPDKT HHHHHHHHCCCCCCC | 9.18 | 30622161 | |
147 | Acetylation | NFGYSYAKRMIDVQN CCCHHHHHHHHHCCC | 33.98 | 23954790 | |
200 | Phosphorylation | HKVHLAKSSGSALTV EEEEEHHCCCCCEEE | 34.03 | 20068231 | |
201 | Phosphorylation | KVHLAKSSGSALTVW EEEEHHCCCCCEEEE | 35.74 | 20068231 | |
203 | Phosphorylation | HLAKSSGSALTVWGT EEHHCCCCCEEEECC | 23.27 | 25693802 | |
206 | Phosphorylation | KSSGSALTVWGTGNP HCCCCCEEEECCCCC | 17.58 | 25693802 | |
287 | Phosphorylation | FKKTASNSKLRTYLP EEEEECCCCCHHCCC | 30.48 | - | |
306 | Ubiquitination | TPFKQAVKETCAWFT CCHHHHHHHHHHHHH | 50.77 | - | |
316 | Phosphorylation | CAWFTDNYEQARK-- HHHHHCCHHHHHC-- | 16.54 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FCL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FCL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FCL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RBBP7_HUMAN | RBBP7 | physical | 22863883 | |
PCBP3_HUMAN | PCBP3 | physical | 26186194 | |
ARFP1_HUMAN | ARFIP1 | physical | 26344197 | |
G6PD_HUMAN | G6PD | physical | 26344197 | |
GALE_HUMAN | GALE | physical | 26344197 | |
HNRH1_HUMAN | HNRNPH1 | physical | 26344197 | |
KDM3A_HUMAN | KDM3A | physical | 26344197 | |
NTM1A_HUMAN | NTMT1 | physical | 26344197 | |
MSS4_HUMAN | RABIF | physical | 26344197 | |
SC31A_HUMAN | SEC31A | physical | 26344197 | |
XPO1_HUMAN | XPO1 | physical | 26344197 | |
PCBP3_HUMAN | PCBP3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-147, AND MASS SPECTROMETRY. |